-
Loading metrics
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults
- Juliet Mpendo,
- Gaudensia Mutua,
- Julien Nyombayire,
- Rosine Ingabire,
- Annet Nanvubya,
- Omu Anzala,
- Etienne Karita,
- Peter Hayes,
- Jakub Kopycinski,
- Len Dally
x
- Published: August 7, 2015
- https://doi.org/10.1371/journal.pone.0134287